Trial description:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Contact name:
Dr Christine Parkinson
Trial start date:
Wednesday, March 27, 2019
Trial end date:
Friday, March 31, 2023
Trial tumour type:
Gynaecological
Show on Radiotherapy:
No